Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

Caitlin E. Cox

June 13, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Daily News

CV Health Starts to Decline Around Age 10

Todd Neale

December 23, 2024

News Daily News

Class I Recall for 350,000 Medtronic Defibrillators: FDA

Michael O'Riordan

July 19, 2023

News Daily News

COVID-19: TCTMD’s Dispatch for May Week 1

Todd Neale

May 02, 2022

News Daily News

Earbuds, Smart Pens May Inhibit Cardiac Devices if Carried Too Close

Yael L. Maxwell

March 03, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 1

Todd Neale

February 28, 2022

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 4

Shelley Wood

June 21, 2021

News Daily News

CV Complications of Malaria Rare but Portend Poor Prognosis

Michael O'Riordan

February 22, 2021

News Daily News

Understanding How Flu Viruses Affect the Heart Could Boost COVID-19 Care

Caitlin E. Cox

October 05, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

Advertisement

AI-Supported Coaching Shows Promise for Improving Glycemic Control

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

CV Health Starts to Decline Around Age 10

Class I Recall for 350,000 Medtronic Defibrillators: FDA

COVID-19: TCTMD’s Dispatch for May Week 1

Earbuds, Smart Pens May Inhibit Cardiac Devices if Carried Too Close

COVID-19: TCTMD’s Dispatch for March Week 1

COVID-19: TCTMD’s Daily Dispatch for June Week 4

CV Complications of Malaria Rare but Portend Poor Prognosis

Understanding How Flu Viruses Affect the Heart Could Boost COVID-19 Care

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content